Clinical Trial Update: Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of the combination of pertuzumab and cetuximab in previously treated locally advanced or metastatic colorectal cancer; results were posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Adenocarcinoma of the Rectum
• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Perjeta (pertuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-02-23